These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16683783)

  • 21. A novel neuraminidase deletion mutation conferring resistance to oseltamivir in clinical influenza A/H3N2 virus.
    Abed Y; Baz M; Boivin G
    J Infect Dis; 2009 Jan; 199(2):180-3. PubMed ID: 19046066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Several generations of chemoenzymatic synthesis of oseltamivir (Tamiflu): evolution of strategy, quest for a process-quality synthesis, and evaluation of efficiency metrics.
    Werner L; Machara A; Sullivan B; Carrera I; Moser M; Adams DR; Hudlicky T; Andraos J
    J Org Chem; 2011 Dec; 76(24):10050-67. PubMed ID: 22007598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007.
    Tashiro M; McKimm-Breschkin JL; Saito T; Klimov A; Macken C; Zambon M; Hayden FG;
    Antivir Ther; 2009; 14(6):751-61. PubMed ID: 19812437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of the anti-influenza agent (-)-oseltamivir free base and (-)-methyl 3-epi-shikimate.
    Rawat V; Dey S; Sudalai A
    Org Biomol Chem; 2012 May; 10(20):3988-90. PubMed ID: 22522650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Editorial commentary: viral susceptibility and the choice of influenza antivirals.
    Monto AS
    Clin Infect Dis; 2008 Aug; 47(3):346-8. PubMed ID: 18582205
    [No Abstract]   [Full Text] [Related]  

  • 26. Neuraminidase inhibitors and their role in avian and pandemic influenza.
    Crusat M; de Jong MD
    Antivir Ther; 2007; 12(4 Pt B):593-602. PubMed ID: 17944267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid identification of oseltamivir-resistant influenza A(H1N1) viruses with H274Y mutation by RT-PCR/restriction fragment length polymorphism assay.
    Guo L; Garten RJ; Foust AS; Sessions WM; Okomo-Adhiambo M; Gubareva LV; Klimov AI; Xu X
    Antiviral Res; 2009 Apr; 82(1):29-33. PubMed ID: 19428592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. General practitioners' management of influenza with or without neuraminidase inhibitors.
    Carrat F; El Sawi A; Grandmottet G; Schlemmer C; Gaillat J
    Eur J Gen Pract; 2007; 13(3):157-9. PubMed ID: 17853179
    [No Abstract]   [Full Text] [Related]  

  • 29. Influenza virus susceptibility and resistance to oseltamivir.
    Aoki FY; Boivin G; Roberts N
    Antivir Ther; 2007; 12(4 Pt B):603-16. PubMed ID: 17944268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A concise synthesis of (-)-oseltamivir.
    Trost BM; Zhang T
    Angew Chem Int Ed Engl; 2008; 47(20):3759-61. PubMed ID: 18399551
    [No Abstract]   [Full Text] [Related]  

  • 31. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(35):969-72. PubMed ID: 19745803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Symmetry-based design for the chemoenzymatic synthesis of oseltamivir (Tamiflu) from ethyl benzoate.
    Sullivan B; Carrera I; Drouin M; Hudlicky T
    Angew Chem Int Ed Engl; 2009; 48(23):4229-31. PubMed ID: 19425033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiviral drugs for influenza.
    Med Lett Drugs Ther; 2008 Dec 15-29; 50(1301-1302):98-9, 104; quiz p following 104. PubMed ID: 19078865
    [No Abstract]   [Full Text] [Related]  

  • 34. Antiviral management of seasonal and pandemic influenza.
    Hayden FG; Pavia AT
    J Infect Dis; 2006 Nov; 194 Suppl 2():S119-26. PubMed ID: 17163384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug resistance. A 'wimpy' flu strain mysteriously turns scary.
    Enserink M
    Science; 2009 Feb; 323(5918):1162-3. PubMed ID: 19251605
    [No Abstract]   [Full Text] [Related]  

  • 36. Antivirals and influenza: frequency of resistance.
    Monto AS
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S110-2. PubMed ID: 18820569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus.
    Rungrotmongkol T; Intharathep P; Malaisree M; Nunthaboot N; Kaiyawet N; Sompornpisut P; Payungporn S; Poovorawan Y; Hannongbua S
    Biochem Biophys Res Commun; 2009 Jul; 385(3):390-4. PubMed ID: 19463784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New, azide-free transformation of epoxides into 1,2-diamino compounds: synthesis of the anti-influenza neuraminidase inhibitor oseltamivir phosphate (Tamiflu).
    Karpf M; Trussardi R
    J Org Chem; 2001 Mar; 66(6):2044-51. PubMed ID: 11300898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment.
    Smith JR; Sacks S
    Int J Clin Pract; 2009 Apr; 63(4):596-605. PubMed ID: 19335705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of the Diels-Alder adduct of pyrrole in organic synthesis. Formal racemic synthesis of Tamiflu.
    Kamimura A; Nakano T
    J Org Chem; 2010 May; 75(9):3133-6. PubMed ID: 20364872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.